Taysha Gene Therapies TSHA
NASDAQ TSHA
$3.88 -0.13 (-3.25%)
As of: Oct 23, 2026 · 1:38 PM EDT

Taysha Gene Therapies (TSHA) Other Investing Activities (2023 - 2025)

Updated

Analysis

Taysha Gene Therapies (TSHA) Other Investing Activities (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,134.76 Bn 1,103.34 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 634.69 Bn 554.55 Bn 17.30 Bn 352.00 Mn
3 AbbVie 506.51 Bn 479.62 Bn 12.70 Bn -51.00 Mn
4 Merck 357.95 Bn 312.33 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 293.14 Bn 257.13 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 265.38 Bn 239.06 Bn 12.86 Bn 174.00 Mn
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 195.16 Bn 169.36 Bn 6.22 Bn 20.00 Mn
9 Pfizer 170.88 Bn 117.53 Bn 10.94 Bn -1.00 Mn
10 Taysha Gene Therapies 1.43 Bn 80.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3,000.00
Sep 30, 2025 60,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 7,000.00
Dec 31, 2023 7,000.00
API Access

Taysha Gene Therapies Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=TSHA&period=max&api_key=YOUR_API_KEY